Childhood non-Hodgkin's lymphoma: Recent advances

European Journal of Cancer, Supplement

Volumn 1, Issue 6 SPEC. ISS., 2003, Pages 15-21

  Patte, Catherine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

BURKITT LYMPHOMA; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; LYMPHOBLAST; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT;

EID: 5144224157     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6349(03)90005-X     Document Type: Conference Paper

References (33)

1. Patte C., Sakiroglu C., Ansoborlo S., et al. Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Française d'Oncologie Pediatrique LMB89 protocol. Ann Oncol. 13:2002;789-795
2. Pui C.H., Mahmoud H.H., Wiley J.M., et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. J Clin Oncol. 19:2001;697-704
3. Murphy S.B., Hustu H.O. A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma. Cancer. 45:1980;630-637
4. Link M.P., Donaldson S.S., Berard C.W., et al. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med. 322:1990;1169-1174
5. Patte C., Philip T., Rodary C., et al. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol. 4:1986;1219-1226
6. Patte C., Philip T., Rodary C., et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol. 9:1991;123-132
7. Philip T., Hartmann O., Biron P., et al. High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma. J Clin Oncol. 6:1988;1118-1124
8. Patte C. B-acute lymphoblastic leukemia. The European experience. Int J Pediatr Hematol/Oncol. 5:(2-4):1998;81-88
9. Gentet J.C., Patte C., Quintana E., et al. Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology. J Clin Oncol. 8:1990;661-665
10. Patte C., Auperin A., Michon J., et al. The Societe Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 97:2001;3370-3379
11. Gerrard M., Cairo M.S., Weston C., et al. Results of the FAB international study in children and adolescents with localised resected B-cell lymphoma (large cell, Burkitt and Burkittlike). J Clin Oncol. 22:2003;795. (abstr 3197, 39th ASCO mtg)
12. Patte C., Gerrard M., Auperin A., et al. Results of the randomised international trial FAB LMB96 for the "intermediate risk" childhood and adolescent B-cell lymphoma: reduced therapy is efficacious. J Clin Oncol. 22:2003;796. (abstr 3198, 39th ASCO mtg)
13. Cairo M.S., Gerrard M., Sposto R., et al. Results of a randomized FAB LMB96 international study in children and adolescents with advanced (bone marrow and/or CNS) B-NHL (large cell, Burkitt and Burkitt-like): patients with L3ALL leukemia/CNS have an excellent prognosis. J Clin Oncol. 22:2003;796. (abstr 3199, 39th ASCO mtg)
14. Reiter A., Schrappe M., Parwaresch R., et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group. J Clin Oncol. 13:1995;359-372
15. Reiter A., Schrappe M., Tiemann M., et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood. 94:1999;3294-3306
16. Reiter A., Schrappe M., Zimmermann M., et al. Randomised trial of high dose methotrexate infusion over 24 hours versus 4 hours as part of a combination therapy for childhood and adolescent B-cell neoplasms. A report of the BFM group. J Pediatr Hematol Oncol. 25:2003;S2. (abstr, 1st Int Symp on Childhood and Adolescent NHL)
17. Schwenn M.R., Mahmoud H., Bowman P.W., et al. The addition of VP-Ifosfamide did not improve EFS for CNS negative patients with advanced stage small noncleaved lymphoma or B-cell ALL: a POG study. J Clin Oncol. 21:2001;. abstr 1465 (abstr, ASCO mtg)
18. Magrath I., Adde M., Shad A., et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 14:1996;925-934
19. Spreafico F., Massimino M., Luksch R., et al. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children. J Clin Oncol. 20:2002;2783-2788
20. Soussain C., Patte C., Ostronoff M., et al. Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood. 85:1995;664-674
21. Hoelzer D., Ludwig W.D., Thiel E., et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood. 87:1996;495-508
22. Laver J., Weinstein H.J., Hutchison R., et al. Lineage-specific differences in outcome for advanced stage large cell lymphoma in children and adolescents: results of a randomized phase III POG trial. Blood. 98:2001;. abstr 1455 (abstr, ASH mtg)
23. Anderson J.R., Wilson J.F., Jenkin D.T., et al. Childhood nonHodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med. 308:1983;559-565
24. Patte C., Kalifa C., Flamant F., et al. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol. 20:1992;105-113
25. Reiter A., Schrappe M., Ludwig W.D., et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 95:2000;416-421
26. Amylon M.D., Shuster J., Pullen J., et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia. 13:1999;335-342
27. Milpied N., Ifrah N., Kuentz M., et al. Bone marrow transplantation for adult poor-prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol. 73:1989;82-87
28. Boissel N., Auclerc M.F., Lheritier V., et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 21:2003;774-780
29. Brugieres L., Deley M.C., Pacquement H., et al. CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood. 92:1998;3591-3598
30. Seidemann K., Tiemann M., Schrappe M., et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHLBFM 90. Blood. 97:2001;3699-3706
31. Williams D.M., Hobson R., Imeson J., et al. Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens. Br J Haematol. 117:2002;812-820
32. Le Deley M.C., Reiter A., Wiliams D., et al. Prognostic factors in childhood anaplastic large cell lymphoma: results of the European Intergroup study. Ann Oncol. 10:1999;6. (abstr, Lugano mtg)
33. Hoelzer D., Gokbuget N., Digel W., et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood. 99:2002;4379-4385